Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up

Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up

Aim. To investigate the prognostic value of renal function and to estimate glomerular filtration rate (GFR) changes during a 5-year follow-up of patients receiving warfarin therapy. Subjects and methods. 200 patients (124 men, 76 women) mainly from a group at high risk for thromboembolic events (mea...

Full description

Bibliographic Details
Main Authors:	O A Zemlyanskaya, E S Kropacheva, A B Dobrovolsky, E P Panchenko
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2017-09-01
Series:	Терапевтический архив
Subjects:	warfarin chronic kidney disease glomerular filtration rate thromboembolic events bleedings
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/32313/pdf

Similar Items

SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up)
by: E. S. Kropacheva, et al.
Published: (2017-05-01)

THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a prospective 10-year follow-up study)
by: E. S. KROPACHEVA, et al.
Published: (2017-12-01)

Incidence and risk factors of warfarin therapy complications in community hospitals, central and eastern regions, Thailand: a retrospective, multicenter, cohort study
by: Benyapha Sombat, et al.
Published: (2023-06-01)

THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY
by: T. V. Kozlova, et al.
Published: (2016-01-01)

CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY)
by: E. S. Kropacheva, et al.
Published: (2018-05-01)

Adverse clinical outcomes of warfarin therapy and predictors among adult outpatients at public hospitals in Nekemte town, western Ethiopia: A retrospective cross-sectional study
by: Firafan Shuma Teka, et al.
Published: (2024-06-01)

Whether Warfarin Therapy is Associated with Damage on Renal Function in Chinese Patients with Nonvalvular Atrial Fibrillation
by: Yu Kong, et al.
Published: (2016-01-01)

Efficacy and safety of combined aspirin and warfarin therapy after heart valve replacement: a systematic review and meta-analysis of randomized clinical trials
by: E. Z. Golukhova, et al.
Published: (2022-09-01)

Could DOAC Be a Better Choice Than Warfarin in Low Compliance Patients with Fontan Procedure?
by: Jisoo Park, et al.
Published: (2021-05-01)

Temporal Changes in Long‐Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era
by: Kazuhisa Kaneda, et al.
Published: (2024-08-01)

CONSIDERING QUESTION OF SAFETY OF DIRECT ORAL ANTICOAGULANTS: THE RESULTS OF THE COMPARISON OF APIXABAN AND WARFARIN
by: Igor S. Yavelov
Published: (2018-12-01)

Management of warfarin complications in the emergency department
by: Mahmut Özdemir, et al.
Published: (2020-05-01)

Acute Abdomen Due to Uncontrolled Use of Warfarin: Spontaneous Intra-abdominal
by: Fatih Dal, et al.
Published: (2017-12-01)

Fixed-Dose Factor Eight Inhibitor Bypassing Activity (FEIBA) in the Management of Warfarin-Associated Coagulopathies
by: Francisco Ibarra, et al.
Published: (2022-04-01)

Genetic variations in the transcription factors GATA4 and GATA6 and bleeding complications in patients receiving warfarin therapy
by: Yee J, et al.
Published: (2019-05-01)

Rivaroxaban vs. warfarin for the treatment and prevention of venous thromboembolism: A meta-analysis
by: Zhuang Liu, et al.
Published: (2023-04-01)

Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin
by: O. A. Panibratiuk, et al.
Published: (2020-06-01)

Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
by: N. Sh. Zagidullin, et al.
Published: (2021-10-01)

Severe Subconjunctival Bleeding in a Patient with Concomitant Use of Warfarin and Valproic Acid
by: Pinzon R. T., et al.
Published: (2024-06-01)

SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS
by: E. S. Kropacheva
Published: (2016-01-01)

Comparison of the Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients with or Susceptible to Thromboembolic Events
by: Foroud Shahbazi, et al.
Published: (2023-09-01)

SELECTING AN OPTIMAL LONG-TERM ANTICOAGULANT THERAPY FOR A PATIENT WITH ATRIAL FIBRILLATION AND RECURRENT MINOR HEMORRHAGE. CLINICAL FOLLOW-UP
by: E. S. Kropacheva, et al.
Published: (2017-05-01)

Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran
by: N. A. Novikova, et al.
Published: (2021-05-01)

Thromboembolic Events in Users of Warfarin Treated with Different Skeletal Muscle Relaxants
by: Charles E. Leonard, et al.
Published: (2022-08-01)

Comparison of Clinical Characteristics, Risk Factors, and Risk Scores of Patients with and without Bleeding Episodes During Warfarin Treatment
by: Şaban Esen, et al.
Published: (2024-09-01)

Potential clinical benefits of warfarin in end‐stage cancers: A retrospective analysis
by: Osamu Imataki, et al.
Published: (2023-01-01)

Comparison of the Cockroft–Gault, simplified Modification of Diet in Renal Disease, and Chronic Kidney Disease Epidemiology Collaboration formulas in the determination of chronic kidney disease advancement
by: Jolanta Szeliga-Król, et al.
Published: (2016-09-01)

Studies on renal basement membranes
by: Cotter, T, et al.
Published: (1979)

Mekanik Kalp Kapaklı Hastalarda Antikoagülan Kullanımı ve Warfarin Direnci
by: Ergun Salman, et al.
Published: (2015-02-01)

The Analysis of Patients Admitted to the Emergency Department Due to Complications Related to Warfarin Treatment
by: Mustafa Burak Sayhan, et al.
Published: (2014-12-01)

Physical Activity and Renal Function: Results of the Entry Phase of the Fasa Cohort Study
by: M Rostami Chijan, et al.
Published: (2024-03-01)

Warfarin Dosing and Time Required to Reach Therapeutic International Normalized Ratio in Patients with Hypercoagulable Conditions
by: Pushpinderdeep Kahlon, et al.
Published: (2016-11-01)

Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study
by: Salih Kilic, et al.
Published: (2018-01-01)

ADVANTAGES AND DISADVANTAGES OF WARFARIN AND PRADAXA THERAPY FOR VENOUS THROMBOEMBOLISM
by: B. S. Sukovatykh, et al.
Published: (2018-01-01)

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study
by: Matthew A. Wanat, et al.
Published: (2019-10-01)

One-Year Renal Function in Patients with Chronic Renal Failure and Metabolic Syndrome
by: Mojgan Mortazavi, et al.
Published: (2018-11-01)

Evaluation of adverse drug reaction in patients warfarin therapy
by: Norisca Aliza Putriana, et al.
Published: (2022-01-01)

Do we need new scales for assessing the risk of thromboembolic events and bleeding for patients with chronic kidney disease?
by: I. Mykhaloiko, et al.
Published: (2020-09-01)

Bleeding associated with self-medication in warfarin users: A prospective observational study in Ijuí (Brazil)
by: Christiane Colet, et al.
Published: (2023-01-01)

Effects of pharmacist counseling on outpatients receiving warfarin at Songklanagarind Hospital
by: S Krittathanmakul, et al.
Published: (2006-04-01)